First Time Loading...
A

Aceso Life Science Group Ltd
HKEX:474

Watchlist Manager
Aceso Life Science Group Ltd
HKEX:474
Watchlist
Price: 0.144 HKD Market Closed
Updated: May 21, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

5.3B
-16%
Assets
Growth Rates:
1 Year
-8%
3 Years
+3%
5 Years
+0%
7 Years
-
10 Years
-
4B
-15%
Liabilities
Growth Rates:
1 Year
-2%
3 Years
+36%
5 Years
+43%
7 Years
-
10 Years
-
1.3B
-18%
Equity
Growth Rates:
1 Year
-24%
3 Years
-41%
5 Years
-48%
7 Years
-
10 Years
-

Balance Sheet Decomposition
Aceso Life Science Group Ltd

5.3B
Assets
4B
Liabilities
5.3B
Assets
4B
Liabilities
Current Assets 1.4B
Cash & Short-Term Investments 341m
Receivables 757m
Other Current Assets 348m
Non-Current Assets 3.9B
Long-Term Investments 3.3B
PP&E 273m
Intangibles 171m
Other Non-Current Assets 100m
Current Liabilities 2.3B
Accounts Payable 8m
Other Current Liabilities 2.3B
Non-Current Liabilities 1.7B
Long-Term Debt 141m
Other Non-Current Liabilities 1.6B

Balance Sheet
Aceso Life Science Group Ltd

Rotate your device to view
Balance Sheet
Currency: HKD
Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023
Assets
Cash & Cash Equivalents
416
204
296
849
781
267
382
214
291
741
Cash
416
204
296
849
781
267
382
16
96
554
Cash Equivalents
0
0
0
0
0
0
0
198
195
187
Short-Term Investments
0
2 957
4 860
1 241
1 258
1 404
199
588
522
415
Total Receivables
524
821
866
946
760
902
914
756
1 065
757
Accounts Receivables
10
8
0
80
123
99
61
135
149
115
Other Receivables
514
813
866
866
636
803
853
621
916
642
Inventory
3
1
0
9
23
6
89
458
374
354
Other Current Assets
45
46
634
45
60
76
50
10
14
30
Total Current Assets
988
4 028
6 656
3 089
2 883
2 655
1 634
2 026
2 266
2 297
PP&E Net
74
84
83
569
541
450
411
291
283
281
PP&E Gross
74
84
83
569
541
450
411
291
283
0
Accumulated Depreciation
11
16
19
31
97
161
181
259
315
0
Intangible Assets
0
0
0
179
179
175
173
156
158
171
Goodwill
0
0
0
415
99
99
13
0
0
0
Note Receivable
7
56
0
127
205
122
236
94
28
47
Long-Term Investments
1 061
1 288
1 424
793
952
1 982
2 503
3 524
3 454
3 451
Other Long-Term Assets
701
736
147
171
171
72
63
74
74
54
Other Assets
0
0
0
415
99
99
13
0
0
0
Total Assets
2 830
N/A
6 193
+119%
8 428
+36%
5 343
-37%
5 030
-6%
5 555
+10%
5 033
-9%
6 165
+22%
6 263
+2%
6 301
+1%
Liabilities
Accounts Payable
25
0
0
61
77
15
37
4
6
13
Short-Term Debt
0
0
203
150
0
0
0
0
0
0
Current Portion of Long-Term Debt
210
573
464
747
767
627
770
794
2 136
2 151
Other Current Liabilities
28
551
630
383
411
250
242
298
309
691
Total Current Liabilities
262
1 123
1 297
1 342
1 255
892
1 049
1 096
2 451
2 855
Long-Term Debt
14
145
165
199
605
1 814
1 426
1 337
245
193
Deferred Income Tax
0
0
0
134
106
65
62
90
111
100
Minority Interest
5
0
208
237
272
153
6
632
825
1 026
Other Liabilities
0
0
99
106
0
0
0
628
629
578
Total Liabilities
281
N/A
1 268
+351%
1 768
+39%
2 019
+14%
2 238
+11%
2 924
+31%
2 543
-13%
3 783
+49%
4 261
+13%
4 752
+12%
Equity
Common Stock
199
29
36
42
49
53
61
69
74
73
Retained Earnings
680
1 030
1 855
1 616
2 029
1 563
1 845
2 476
2 914
1 476
Additional Paid In Capital
2 824
3 302
3 647
4 276
4 273
4 353
4 531
4 727
4 811
0
Unrealized Security Profit/Loss
204
562
0
631
489
218
233
0
0
0
Treasury Stock
0
0
0
0
0
0
0
0
5
0
Other Equity
2
2
1
9
9
6
24
62
36
0
Total Equity
2 549
N/A
4 925
+93%
6 660
+35%
3 324
-50%
2 792
-16%
2 631
-6%
2 490
-5%
2 382
-4%
2 002
-16%
1 549
-23%
Total Liabilities & Equity
2 830
N/A
6 193
+119%
8 428
+36%
5 343
-37%
5 030
-6%
5 555
+10%
5 033
-9%
6 165
+22%
6 263
+2%
6 301
+1%
Shares Outstanding
Common Shares Outstanding
2 122
3 779
4 249
4 884
4 898
5 285
6 092
6 932
7 327
7 382

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 139,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.